Xact Kapitalforvaltning’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Xact Kapitalforvaltning’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$656K	Hold	12,844	–	–	0.01%	640
2019 Q4	$1.02M	Buy	12,844 +4,300	+50%	+$255K	0.02%	608
2019 Q3	$415K	Hold	8,544	–	–	0.01%	1022
2019 Q2	$449K	Hold	8,544	–	–	0.01%	984
2019 Q1	$452K	Hold	8,544	–	–	0.01%	977
2018 Q4	$351K	Buy	8,544 +700	+9%	+$26.2K	0.01%	1138
2018 Q3	$298K	Buy	7,844 +800	+11%	+$35.4K	0.01%	1370
2018 Q2	$318K	Buy	7,044 +1,100	+19%	+$50.1K	0.01%	1309
2018 Q1	$287K	Buy	5,944 +800	+16%	+$44.6K	0.01%	1279
2017 Q4	$202K	Buy	+5,144	New	+$192K	﹤0.01%	1253

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Xact Kapitalforvaltning's GBT Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Global Blood Therapeutics, Inc. (GBT) position steady in Q1 2020 at 12,844 shares worth $656K. The position accounts for 0.01% of the portfolio, ranked #640.

Xact Kapitalforvaltning first reported a position in GBT in Q4 2017 and has held it in 10 quarters since. The position peaked at $1.02M in Q4 2019. 220 funds tracked by Wall St. Rank hold GBT as of Q1 2020.

Xact Kapitalforvaltning held 12,844 shares of Global Blood Therapeutics, Inc. worth $656K as of Q1 2020.
Xact Kapitalforvaltning left its Global Blood Therapeutics, Inc. share count unchanged in Q1 2020.
Global Blood Therapeutics, Inc. made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #640 holding.
Xact Kapitalforvaltning first reported a position in Global Blood Therapeutics, Inc. in Q4 2017 and has held it in 10 quarters since.
Xact Kapitalforvaltning's Global Blood Therapeutics, Inc. position peaked at $1.02M in Q4 2019.
220 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.